CIK: 0001744967 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 17, 2026
Total Value ($000): $969,257 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IVA | INVENTIVA SA | 5,194,805 | $24,156 | 2.5% | $4.65 | — | ADS | 46124U107 |
| RANI | RANI THERAPEUTICS HLDGS INC | 8,500,000 | $11,475 | 1.2% | $1.51 | 0.0% | COM CL A | 753018100 |
| XFOR | X4 PHARMACEUTICALS INC | 1,960,000 | $7,840 | 0.8% | $3.63 | 0.0% | COM NEW | 98420X202 |
| STRO | SUTRO BIOPHARMA INC | 204,503 | $2,366 | 0.2% | $9.49 | 0.0% | COM SHS | 869367201 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SRRK | SCHOLAR ROCK HLDG CORP | 6,897,652 (+22.9%) | $303,842 (+45.4%) | 31.3% | $14.61 | +156.7% | COM | 80706P103 |
| KLRS | KALARIS THERAPEUTICS INC | 12,948,081 (+13.1%) | $109,282 (+65.2%) | 11.3% | $9.40 | -32.0% | COM | 482929106 |
| ALMS | ALUMIS INC | 5,756,984 (+19.9%) | $56,188 (+193.3%) | 5.8% | $9.30 | -24.9% | COM | 022307102 |
| JBIO | JADE BIOSCIENCES INC | 968,798 (+82.4%) | $14,949 (+226.1%) | 1.5% | $23.56 | -50.2% | COM NEW | 008064206 |
| GOSS | GOSSAMER BIO INC | 7,222,559 (+17.8%) | $22,390 (+38.9%) | 2.3% | $1.41 | +102.4% | COM | 38341P102 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| LENZ | LENZ THERAPEUTICS INC | 343,012 | $15,977 | 1.6% | $20.79 | +40.2% | — | 52635N103 |
| — | AVADEL PHARMACEUTICALS PLC | 675,504 | $10,315 | 1.1% | $14.06 | — | — | G29687103 |
| AURA | AURA BIOSCIENCES INC | 584,849 | $3,614 | 0.4% | $5.85 | +1.5% | — | 05153U107 |
| ZYME | ZYMEWORKS INC | 207,901 | $3,551 | 0.4% | $8.72 | +150.1% | — | 98985Y108 |
| SRZN | SURROZEN INC | 241,400 | $3,110 | 0.3% | $11.62 | +39.2% | — | 86889P208 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 30,285 | $3,058 | 0.3% | $17.86 | +494.0% | — | 76243J105 |
| — | SUTRO BIOPHARMA INC | 2,196,814 | $1,908 | 0.2% | $7.26 | — | — | 869367102 |
| TERN | TERNS PHARMACEUTICALS INC | 135,573 | $1,018 | 0.1% | $21.92 | +5.4% | — | 880881107 |
| BOLT | BOLT BIOTHERAPEUTICS INC | 48,830 | $260 | 0.0% | $6.62 | -18.9% | — | 097702203 |
| SRZNW | SURROZEN INC | 99,999 | $2 | 0.0% | $0.19 | — | — | 86889P117 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MLYS | MINERALYS THERAPEUTICS INC | 5,871,018 (-6.3%) | $213,059 (-10.3%) | 22.0% | $16.38 | +144.9% | COM | 603170101 |
| CTNM | CONTINEUM THERAPEUTICS INC | 72,245 (-87.4%) | $826 (-87.7%) | 0.1% | $16.10 | -29.2% | CL A | 21217B100 |
| VTVT | VTV THERAPEUTICS INC | 298,496 (-20.3%) | $11,937 (+36.5%) | 1.2% | $14.92 | +85.9% | CL A NEW | 918385204 |
| ACLX | ARCELLX INC | 60,873 (-25.0%) | $3,969 (-40.4%) | 0.4% | $16.49 | +383.8% | COMMON STOCK | 03940C100 |
| PVLA | PALVELLA THERAPEUTICS INC NE | 104,817 (-50.0%) | $10,971 (-16.5%) | 1.1% | $15.71 | +443.1% | COM | 697947109 |
| UPB | UPSTREAM BIO INC | 736,047 (-23.5%) | $19,984 (+10.4%) | 2.1% | $22.33 | +11.5% | COM | 91678A107 |
| NKTX | NKARTA INC | 3,507,666 (-6.9%) | $6,489 (-16.8%) | 0.7% | $21.30 | -90.6% | COM | 65487U108 |
| — | NUVATION BIO INC | 124,119 (-6.9%) | $41 (+52.0%) | 0.0% | $0.28 | — | *W EXP 02/10/202 | 67080N119 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SEPN | SEPTERNA INC | 3,149,128 | $87,798 | 9.1% | $22.17 | +7.7% | COM | 81734D104 |
| NGNE | NEUROGENE INC | 1,717,127 | $35,373 | 3.6% | $20.31 | +22.6% | COM | 64135M105 |
| ABVX | ABIVAX SA | 75,442 | $10,174 | 1.0% | $84.90 | — | SPONSORED ADS | 00370M103 |
| AQST | AQUESTIVE THERAPEUTICS INC | 2,500,000 | $16,150 | 1.7% | $4.32 | +44.1% | COM | 03843E104 |